期刊文献+

阻断共刺激信号在异种小动物心脏移植中诱导免疫耐受的研究

Study of Immune Tolerance to Cardiac Xenografts Induced by Blockading B7/CD28 and CD40/CD40L Interactions in Guinea-pig to Rat
原文传递
导出
摘要 目的在非协调性异种小动物豚鼠-大鼠心脏移植模型当中,通过单克隆抗体阻断T细胞B7/CD28及CD40/CD40L激活通路途径来探讨T细胞在异种移植延迟性免疫排斥中的作用,探索诱导异种移植T细胞外周耐受的可能性。方法将供体三色豚鼠和受体SD大鼠随即分成四组:A组(对照组),在移植前一天大鼠腹腔内注射CVF 0.4mg/kg;B组(B7mAb组),在移植当天大鼠腹腔内注射B7单抗0.1mg,余处理同A组;C组(CD40LmAb组),在移植当天大鼠腹腔内注射CD154单抗0.1mg,余处理同A组;D组(联合组),在移植当天大鼠腹腔内注射B7单抗0.1mg、CD154单抗0.1mg,余处理同A组。观察各组供心存活的时间,并行移植心脏的常规病理和免疫组化检查。结果对照组移植心脏的存活时间为(19.5±2.7)h,与对照组比较,B7组、CD40L组和联合处理组的移植心脏存活时间均得到了显著的延长,但联合处理组延长最为明显。移植心脏组织病理学检查均呈急性血管排斥反应改变,且以CD8+T细胞浸润为主。结论联合阻断CD28/B7与CD40/CD40L共刺激通路可延长异种移植心脏存活时间。 Objective To investigate the effect of T cells on the delayed xenograft rejection by blockading B7/CD28 and CD40/CD40L interactions,and to investigate the possibility of inducing the immune tolerance to heart xenografts by the way of T cells.Methods Intra-abdominal heterotopic heart transplantation was performed.guinea-pig and SD rat were,respectively,selected as donor and recipient.Experimental animals were randomly divided into four groups:①the control group(group A):recipients were treated with CVF by intraperitoneal injection at the dose of 0.4mg/kg on 20~24 hours before transplantation.② the B7-mAb group(group B):recipients were treated with B7-mAb by intraperitoneal injection at the dose of 100μg before transplanting operation,the other pretreatments were the same as group A.③the CD40L-mAb group(group C):recipients were treated with CD40L-mAb by intraperitoneal injection at the dose of 100μg before transplanting operation,the other pretreatments were the same as group A.④the union group(group D):the recipients were treated with CVF,B7-mAb and CD40L-mAb.Observe the survival time of cardiac xenografts,when no myocardial contractions could be felt,the xenografts were excised and examined histologically and immunohistochemically for CD4+,CD8+ T cells.Results Mean survival time of group A(19.5±2.7)h,the graft survival time was significantly prolonged by blocking B7/CD28 and CD40/CD40L interactions.Some CD8+ T cells(25%of total leukocytes)were found infiltrating,the entire xenografts showed acute vascular rejection.Conclusion The blockade B7/CD28 and CD40/CD40L interactions can prolong the survival of the xenografts.It may provide a new way to treat immune rejection after xenotransplantation.
出处 《医药论坛杂志》 2010年第21期23-25,共3页 Journal of Medical Forum
关键词 异种心脏移植 B7单抗 CD40L单抗 T淋巴细胞 免疫耐受 Heart xenotransplantation B7-mAb CD40L-mAb T-lymphocyte Immune tolerance
  • 相关文献

参考文献5

  • 1冯莉,李幼平.异种移植免疫学研究进展[J].中国修复重建外科杂志,2002,16(4):284-287. 被引量:4
  • 2Gock HM, Cowan PD, Apice JF. Leukocyte recruitment in xenotransplantation [ J ]. Organ Transplant, 2002, 7 (1) :85-91.
  • 3Kellersmann R, Kellersmann A, Thiede A, et al. Comparison of in vivo lymphocyte proliferation between allogeneic and xenogeneic heart transplantation in mice [ J ]. Microsurgery, 2003,23:498.
  • 4陈刚,王西墨,孙黔云,沈世乾,郭晖,王虹,陈利君,吴瑛,朱建国,王婉瑜,熊郁良,陈实.清除补体避免猪到猕猴异种心脏移植超急性排斥反应的实验研究[J].中华器官移植杂志,2003,24(3):157-159. 被引量:4
  • 5Ashton - chess J, Roussel JC, Manez R, et al. Cellular participation in delayed xenograft rejection of hcd55 transgenic pig hearts by baboons [J]. Xenotransplantation,2003,10:446.

二级参考文献10

  • 1Davis EA, Pruitt SK, Greene PS, et al. Inhibition of complement,evoked antibody, and cellular response prevents rejection of pig-toprimate cardiac xenografts. Transplantation, 1996, 62:1018-1023.
  • 2Adams DH, Chen RH, Kadner A, et al. Technique for heterotopic pig heart xenotransplantation in primates. Ann Thorac Surg, 1999,68 : 265-268.
  • 3Leventhal JR, Dalmasso AP, Cromwell JM, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation, 1993, 55:857-866.
  • 4Candinas D, Lesnikoski BA, Robson SC, et al. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. Transplantation,1996, 62:336-342.
  • 5Kobayashi T, Taniguchi S, Neethling FA, et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation, 1997, 64:1255-1261.
  • 6Hunsicker LG, Austen KF. Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement. J Immunol, 1973, 110:128-138.
  • 7Miyama A, Kato T, Minoda I, et al. Activation of terminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor. Japan J Microbiol, 1976, 20:507-516.
  • 8Vogel CW, Mller-Eberhard HJ. The cobra venom factor-dependent C3 convertase of human complement. J Biol Chem, 1982, 257:8292-8299.
  • 9李幼平,马玉奎,何秋明.临床异种大动物器官移植的现状、问题与对策综述[J].中国修复重建外科杂志,1998,12(2):99-107. 被引量:10
  • 10李幼平,何秋明,蔡绍晖,程惊秋.异种移植与中国地方猪种资源的利用[J].中国修复重建外科杂志,1999,13(1):43-46. 被引量:15

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部